|
Novel Tools and Approaches Research Program
|
Research Initiative
|
ATSDR
|
NIEHS
|
Novel Tools and Approaches Research Program
|
|
NSTC Subcommittee on Biological Defense Research and Development - Interagency Bioconvergence Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
OD/OSP
|
The National Science and Technology Council (NSTC) Health Security Threats Bioconvergence Strategic Objective is focused on gaining insight about areas of opportunity and areas of risk for biodefense arising from the convergence of the most recent advances in biosciences with leading edge discoveries in other areas of physical, computational, and life sciences research. The co-leads of the group are Cindy Bruckner-Lea and Ashley Predith at the Department of Energy.
|
|
NSTC Subcommittee on Biological Sciences
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP
|
Advises and assists the Committee on Science and the National Science and Technology Council (NSTC) on Federal policies, procedures and plans in the biological sciences; also explore ways in which the Federal government can increase the overall effectiveness and productivity of its investment in biological sciences research, especially regarding issues that cut across agency boundaries.
|
|
NSTC Subcommittee on Biological Sciences -Interagency Synthetic Biology Working Group (BSSC-SBWG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC
|
OD/OSP, NIBIB
|
Provides coordination and strategic planning to help ensure responsible innovation and significant advances in research in synthetic biology.
|
|
NSTC Subcommittee on Open Science (NSTC SOS)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, ASPR, CDC, FDA
|
OD/DPCPSI/ODSS
|
The NSTC Subcommittee on Open Science advances cross-agency efforts in open science. The newly established NSTC SOS Open Science Infrastructure Subgroup will develop a coordinated, cross-agency approach to implementing digital infrastructure that supports and enables open science. The original group was formed under Obama Administration, but it became a sub committee under the Trump Administration.
|
|
Nutrition Research Coordinating Committee (NRCC)
|
Committee, Work group, Advisory group, or Task Force
|
ACL, AHRQ, CDC, FDA, HRSA, OASH
|
OD/DPCPSI/ONR, NCATS, NCCIH, FIC, CSR, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NIAID, NIAMS, NIBIB, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI, OD/DPCPSI/OAR, OD/DPCPSI/OBSSR, OD/DPCPSI/ODS, OD/DPCPSI/ORWH, OD/DPCPSI/OSC, OD/ECHO
|
The Nutrition Research Coordinating Committee (NRCC) was established by the National Institutes of Health (NIH) Office of the Director in 1975 to improve communication and research coordination of nutrition activities within the NIH and across the federal government. Today it provides an open forum for members to discuss current and future nutrition research challenges and opportunities. The NRCC has broad representation from the NIH institutes and centers. In addition, liaisons from other federal offices and agencies also participate. The NRCC meets monthly, alternating between intra-NIH and interagency meetings. NRCC membership is open to any federal staff member interested in carrying out any trans-NIH or trans-agency nutrition research efforts.
|
|
Obesity Prevention and Control: Combined School-Based Interventions to Increase Healthier Food and Beverage Consumption and Physical Activity
|
Meeting/ Workshop
|
CDC
|
NHLBI
|
Ongoing participation on monthly calls by the Community Guide Coordinating Team.
|
|
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD)
|
Research Initiative
|
CDC
|
NIAID
|
This is a study of the safety, adherence, and efficacy of a fixed-dose combination of drug tenofovir/lamivudine/dolutegravir (TLD) among HIV patients, including those co-infected with tuberculosis, receiving care at PEPFAR (President’s Emergency Plan for AIDS Relief) funded sites in resource limited countries.
|
|
Occupational Exposure Assessment of a-Pinene and related Monoterpenes
|
Research Initiative
|
CDC, FDA
|
NIEHS
|
This research will define the range of exposures present across several industries that routinely handle monoterpene compounds, to determine which working populations are most at risk of elevated exposures to monoterpenes.
|
|
Occupational Exposure Assessment of Emerging Per- and Polyfluoroalkyl Substances (PFAS)
|
Research Initiative
|
CDC
|
NIEHS
|
The primary objectives of this study are to identify PFAS compounds currently in use in commerce or industry and the companies, industries, and worker populations who are manufacturing, processing, or using PFAS products and to conduct targeted occupational exposure assessments in high- and moderate-PFAS volume industries. Based on the results of the exposure assessment, secondary objectives of this study are to assess health effects associated with PFAS exposure. To meet the objectives of this study, we propose four specific aims.
|